Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pyridostigmine for complex regional pain syndrome type I
NL-OMON33787Phase 2Active, not recruiting
- Sponsor
- Vrije University Medical Center
- Start
- Jul 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of pyridostigmine in Complex Regional Pain Syndrome Type 1 (CRPS-1), sponsored by Vrije University Medical Center. Primary endpoints: Inflammatory signs of the affected extremity and Pain score. Started Jul 2009; status: active, not recruiting.
02
Drugs
pyridostigmine
03
Conditions
Complex Regional Pain Syndrome Type 1 (CRPS-1)
Beyond the preview
Go deeper on NL-OMON33787.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON33787.